Northwestern Medicine scientists have identified a signaling pathway that regulates the behavior of two subtypes of glioblastomas.
Year: 2016
A new pathway in the brain can be manipulated to alleviate depression, offering a promising new target for developing a drug that could be effective in individuals for whom other antidepressants have failed.
Feinberg faculty, students and staff gathered to celebrate and advance medical education through workshops, lectures and presentations at the 6th Annual Medical Education Day.
Ronald Ackermann, MD, MPH, has been named senior associate dean for public health and director of the Institute for Public Health and Medicine (IPHAM), succeeding IPHAM’s inaugural leader, Rowland Chang, MD, MPH.
A 3-D printable ink developed by Northwestern scientists produces synthetic bone implants with unique properties to induce bone regeneration.
Dimitri Krainc, MD, PhD, Aaron Montgomery Ward Professor and chair of Neurology, has received the Javits Award from the National Institute of Neurological Disorders and Stroke.
Northwestern University has been awarded a grant from the National Institutes of Health to help scientists across the country study how environmental factors influence health outcomes for children.
Monica Rho, ’05 MD, ’09 GME, traveled to the Paralympic Games in Rio de Janeiro, Brazil as head team physician for the U.S. Paralympic Men’s Soccer Team.
Dai Horiuchi, PhD, assistant professor of Pharmacology, has been awarded a $450,000 research grant from Susan G. Komen to explore a potential targeted therapy against triple-negative breast cancer.
Northwestern Medicine scientists continue to demonstrate that a protein called Hrd1 may be an important target for treating autoimmune diseases.